PRF TECHNOLOGIES LTD (PRFX) Stock Price & Overview
NASDAQ:PRFX • IL0011651580
Current stock price
The current stock price of PRFX is 2.42 USD. Today PRFX is down by -6.2%. In the past month the price decreased by -12.84%. In the past year, price decreased by -80%.
PRFX Key Statistics
- Market Cap
- 1.888M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -160.82
- Dividend Yield
- N/A
PRFX Stock Performance
PRFX Stock Chart
PRFX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to PRFX. When comparing the yearly performance of all stocks, PRFX is a bad performer in the overall market: 97.09% of all stocks are doing better.
PRFX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PRFX. The financial health of PRFX is average, but there are quite some concerns on its profitability.
PRFX Earnings
PRFX Forecast & Estimates
PRFX Groups
Sector & Classification
PRFX Financial Highlights
Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -160.82. The EPS increased by 81.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -130.69% | ||
| ROE | -172.78% | ||
| Debt/Equity | 0 |
PRFX Ownership
PRFX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.75 | 933.096B | ||
| JNJ | JOHNSON & JOHNSON | 20.63 | 586.064B | ||
| MRK | MERCK & CO. INC. | 22.35 | 285.388B | ||
| PFE | PFIZER INC | 9.07 | 151.312B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.56 | 121.598B | ||
| ZTS | ZOETIS INC | 17.21 | 49.875B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.93 | 26.593B | ||
| VTRS | VIATRIS INC | 5.48 | 15.555B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.77 | 11.634B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.093B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.204B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.893B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.75 | 4.144B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PRFX
Company Profile
PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The firm is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustained‑release drug‑delivery platforms that combine proven generic medicines with proprietary extended‑release systems to improve patient outcomes. One of the Company's products is PRF‑110 - a ropivacaine‑based formulation designed to deliver localised, extended postoperative analgesia. The firm also advances OcuRingTD, a bio‑erodible drug‑release ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AI‑powered monitoring, forecasting, and optimisation tools for solar asset performance.
Company Info
IPO: 2020-09-01
PRF TECHNOLOGIES LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442 IL
CEO: Ilan Hadar
Employees: 4
Phone: 97237177051
PRF TECHNOLOGIES LTD / PRFX FAQ
What does PRF TECHNOLOGIES LTD do?
PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The firm is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustained‑release drug‑delivery platforms that combine proven generic medicines with proprietary extended‑release systems to improve patient outcomes. One of the Company's products is PRF‑110 - a ropivacaine‑based formulation designed to deliver localised, extended postoperative analgesia. The firm also advances OcuRingTD, a bio‑erodible drug‑release ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AI‑powered monitoring, forecasting, and optimisation tools for solar asset performance.
What is the stock price of PRF TECHNOLOGIES LTD today?
The current stock price of PRFX is 2.42 USD. The price decreased by -6.2% in the last trading session.
What is the dividend status of PRF TECHNOLOGIES LTD?
PRFX does not pay a dividend.
What is the ChartMill rating of PRF TECHNOLOGIES LTD stock?
PRFX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in PRF TECHNOLOGIES LTD be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRFX.